GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Other Financing

OKUR (OnKure Therapeutics) Other Financing : $57.22 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Other Financing?

OnKure Therapeutics's Other Financing for the three months ended in Dec. 2024 was $55.31 Mil.

OnKure Therapeutics's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was $57.22 Mil.

OnKure Therapeutics Other Financing Historical Data

The historical data trend for OnKure Therapeutics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Other Financing Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Other Financing
-1.38 -0.72 51.22

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Financing Get a 7-Day Free Trial Premium Member Only 53.06 - 5.86 -3.95 55.31

OnKure Therapeutics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $57.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OnKure Therapeutics Other Financing Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Other Financing
Comparable Companies
APLT QNCX GUTS INZY IMRX CNTX ANRO CYCC CUE STRO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
Website
https://www.onkuretherapeutics.com
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.